Pivotal study documentation for submission [Regulatives / Guidelines]

posted by Amalia – Greece, 2018-09-24 16:22 (2477 d 17:30 ago) – Posting: # 19299
Views: 1,783

Dear all,

as this is my first post I will try to be as elaborate as possible.
Is it possible to send for a pivotal study, not from the validation batches, but from a 100,000 tabs batch prepared in the R&D lab (with GMP accreditation)?
If yes, I guess that it is vital for the specifications of your batch to be the same as the ones from the validation batches (which have not been concluded yet).
What documentation is required in order to link the biobatch with the validation batches?

Thank you in advance,

Amalia

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,681 registered users;
63 visitors (0 registered, 63 guests [including 19 identified bots]).
Forum time: 09:52 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5